Authors: WALSH TJ YELDANDI V MCEVOY M GONZALEZ C CHANOCK S FREIFELD A SEIBEL NI WHITCOMB PO JAROSINSKI P BOSWELL G BEKERSKY I ALAK A BUELL D BARRET J WILSON W

Citation: Tj. Walsh et al., SAFETY, TOLERANCE, AND PHARMACOKINETICS OF A SMALL UNILAMELLAR LIPOSOMAL FORMULATION OF AMPHOTERICIN-B (AMBISOME) IN NEUTROPENIC PATIENTS, Antimicrobial agents and chemotherapy, 42(9), 1998, pp. 2391-2398

Authors: LEE JW SUKOVATY RL FARMEN RH DRESSLER DE ALAK A BEKERSKY I

Citation: Jw. Lee et al., TACROLIMUS (FK506) - VALIDATION OF A SENSITIVE ENZYME-LINKED-IMMUNOSORBENT-ASSAY KIT FOR AND APPLICATION TO A CLINICAL PHARMACOKINETIC STUDY, Therapeutic drug monitoring, 19(2), 1997, pp. 201-207

Authors: KEMPE KC DENSMORE T MACFARLANE G ERSFELD D ALAK A SCOTT M

Citation: Kc. Kempe et al., COMPARISON OF THE IMX(R) MEIA AND PRO-TRACTMII ELISA ASSAYS FOR THE DETERMINATION OF TACROLIMUS (PROGRAF(R), FK506) IN WHOLE-BLOOD, Clinical chemistry, 43, 1997, pp. 453-453

Authors: ALAK A MOY S BEKERSKY I

Citation: A. Alak et al., A HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR THE DETERMINATIONOF AMPHOTERICIN-B SERUM CONCENTRATIONS AFTER THE ADMINISTRATION OF AMBISOME, A LIPOSOMAL AMPHOTERICIN-B FORMULATION, Therapeutic drug monitoring, 18(5), 1996, pp. 604-609

Authors: MACFARLANE G SCHELLER D ALAK A ERSFELD D ROESLER J JOHANSON N IKEDA D

Citation: G. Macfarlane et al., STANDARDIZATION OF THE PROTRAC(TM)-II ELISA FOR THE MEASUREMENT OF TACROLIMUS IN WHOLE-BLOOD, Clinical chemistry, 42(6), 1996, pp. 511-511